ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2013 American Transplant Congress

    Utility of Bronchoscopy in Post-Transplant Patients Presenting with Symptoms and Signs of Pneumonia

    M. Gitman, S. Huprikar, S. Factor

    Laboratory Medicine, Yale New Haven Hospital, New Haven, CT; Infectious Diseases, Mount Sinai School of Medicine, New York, NY

    Background: Most studies of the role of bronchoscopy and the epidemiology of pulmonary infections in post-transplant patients focus on stem cell transplant (SCT) recipients. The…
  • 2013 American Transplant Congress

    Adherence with Immunosuppressive Therapy: Results to 4 Years after Kidney Transplantation in the Mycophenolic Acid Observational Renal Transplant (MORE) Study

    D. Tsapepas, A. Langone, L. Chan, A. Wiland, K. McCague, M. Chisholm-Burns

    NY-Presbyterian Hospital-Columbia University Medical Center, New York, NY; Vanderbilt University Medical Center, Nashville, TN; University of Colorado School of Medicine, Aurora, CO; Novartis Pharmaceuticals, East Hanover, NJ; University of Tennessee Health Science Center, Memphis, TN

    Introduction: Provider knowledge of factors influencing adherence with immunosuppression may help identify at-risk patients to allow for intervention.Methods: MORE was a prospective, 4-year, observational study…
  • 2013 American Transplant Congress

    Importance of MDR1 Gene Polymorphisms for Calcineurin Inhibitors Dosage and Early Kidney Graft Function, The

    M. Kravljaca, V. Pravica, E. Savic, V. Brkovic, V. Lezaic, R. Naumovic

    Clinic of Nephrology, Clinical Center of Serbia, Belgrade, Serbia; Institute of Microbiology and Immunology, School of Medicine, University of Belgrade, Belgrade, Serbia; School of Medicine, University of Belgrade, Belgrade, Serbia

    Calcineurin inhibitors (CNIs) are a substrate of P-glycoprotein, the product of the multidrug resistance (MDR1) gene and has been known to undergo extensive hepatic metabolism…
  • 2013 American Transplant Congress

    Older Living Donor Kidney Transplantation vs. Dialysis on the Waiting List and Standard Criteria Deceased Donor Kidney Transplantation: A Decision Analysis

    R. Sapir-Pichhadze, F. Farrokhi, N. David, F. Rob, J. Kim

    Medicine, University of Toronto, Toronto, ON, Canada

    Background: Living donor (LD) kidney transplantation provides improved outcomes compared with deceased donor (DD) kidney transplantation. Little is known about health gains associated with older…
  • 2013 American Transplant Congress

    Amnion-Derived Multipotent Progenitor Cells Support Allograft Tolerance Induction

    K. Anam, Y. Lazdun, P. Davis, R. Banas, E. Elster, T. Davis

    Regenerative Medicine Department, Navy Medical Redearch Center, Silver Spring, MD; Stemnion Inc, , Pittsburgh, PA

    Donor-specific immunological tolerance using high doses of donor bone marrow cells (BMC) has been demonstrated in mixed chimerism-based tolerance induction protocols; however, the development of…
  • 2013 American Transplant Congress

    mCMV Infection Increases Migration of Graft-Reactive CD8+ T Cells into the Allograft Impairing Regulatory T Cell Survival

    I. Ferrer, K. Wood

    Nuffield Department of Surgical Sciences, University of Oxford, Headington, United Kingdom

    The advent of immunosuppression has been invaluable in prolonging survival of transplanted organs. However, systemic immunosuppression renders individuals vulnerable to infections that may trigger rejection…
  • 2013 American Transplant Congress

    Critical Analysis of Retransplantation within 1 Year after Liver Transplantation, A

    A. Rana, M. Porubsky, T. Jie, S. Habib, H. Rilo, B. Kaplan, A. Gruessner, R. Gruessner

    Abdominal Transplantation, University of Arizona, Tucson, AZ

    Context: Five percent of liver transplant recipients require retransplantation within the first year. In light of the critical donor shortage, a critical analysis of risk…
  • 2013 American Transplant Congress

    Impact of Hyperuricemia on Outcomes of Kidney Transplantation: Analysis of the FAVORIT (Folic Acid for Vascular Outcome Reduction in Transplantation) Trial, The

    R. Kalil, S. Campbell, M. Carpenter, M. Weir, T. Pesavento, M. Pfeffer, S. Solomon, W. Haynes, L. Hunsicker

    Medicine, University of Iowa, Iowa City; College of Public Health, University of North Carolina, Chapel Hill; Medicine, University of Maryland, Baltimore; Medicine, Ohio State University, Columbus; Brigham and Women's Hospital, Boston

    Elevated uric acid (UrAc) levels are associated with higher rates of cardiovascular (CV) morbidity and mortality in the general population. Single center studies suggest an…
  • 2013 American Transplant Congress

    Lipocalin-2 in Serum Samples of Recipients Following Liver Transplantation as Predictive and Monitoring Marker for Acute Allograft Rejection

    N. Vallant, H. Maier, M. Kofler, P. Schumpp, S. Schneeberger, R. Oellinger, J. Pratschke, F. Aigner

    Department of Visceral,- Thoracic- and Transplant Surgery, Medical University, Innsbruck, Tyrol, Austria

    PURPOSE: Lipocalin-2 (Lcn-2) has been described as a marker and modulator of inflammation during ischemia/reperfusion injury (IRI) following solid organ transplantation. Aim of this study…
  • 2013 American Transplant Congress

    Early Look at the OPTN Explant Pathology Form Data, An

    A. Harper, E. Edwards, J. Heimbach, R. Hirose, R. Freeman, K. Olthoff

    Uniited Network for Organ Sharing, Research, Richmond, VA; Surgery, Mayo Clinic, Rochester, MN; Surgery, UCSF Medical Center, San Francisco, CA; Surgery, Dartmouth Hitchcock Medical Center, Lebanon, NH; Surgery, The Hosp of the Univ of Pennsylvania, Phildelphia, PA

    Background: Candidates with exceptions for hepatocellular carcinoma (HCC) accounted for 29% of liver transplants during the first 6 months of 2012. OPTN policy requires submission…
  • « Previous Page
  • 1
  • …
  • 34
  • 35
  • 36
  • 37
  • 38
  • …
  • 178
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences